Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
10%
Ph early_phase_1
1
10%
Ph not_applicable
7
70%
Ph phase_1
1
10%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(9)

Detailed Status

Completed9
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (10.0%)
Phase 11 (10.0%)
Phase 31 (10.0%)
N/A7 (70.0%)

Trials by Status

active_not_recruiting110%
completed990%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10